Information about Uterine Fibroid Research
- NICHD news releases about Uterine Fibroids
- NIH International Congress Videocast:
Management of Uterine Fibroids: An Update of the Evidence (July 2007)
This report from the Agency for Healthcare Research and Quality reviewed evidence for treatment options for uterine fibroids and identified research gaps. Read the report.
The goal of the EDR is to serve as an evolving Bioinformatics Resource on genes associated with the uterus.
The purpose of this study is to collect information and tissue samples from women who have uterine fibroids. Collected during surgery, the samples will be used to study genes, proteins, and other aspects of fibroids to better understand how they develop and grow as well as to help improve fertility and reproductive health.
The Agency for Healthcare Research and Quality developed the Fibroid Registry for Outcomes and Data (The FIBROID Registry) to assess changes in symptom severity and health-related quality of life among women who had undergone UAE to treat fibroids. The Registry began in 2000 and enrolled more than 2,100 eligible women. Researchers found that symptoms and quality-of-life measures improved at 12 months after UAE and that 80% of the women were satisfied with the outcomes. Fewer than 3% of women required a hysterectomy within 12 months of having UAE.
Please note: Links to organizations and information included on this page do not indicate endorsement from the NICHD, NIH, or HHS.